Clinical Trials Browser

Phase 2 × Lymphoma × Blood Component Removal × Clear all

NCT01329900 2020-07-08

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

Phase 2 Completed

50 enrolled 7 charts

Lymphoma